A Phase 2, Open-Label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-9)
| Autor: | Jason Westin, John M. Burke, Andrew E. Chapman, Turk Kilavuz, Cindy Xu, Yochi Schmuely, Brad Lane Stanford, Emily Beedle, John Radford |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Blood. 140:6638-6639 |
| ISSN: | 1528-0020 0006-4971 |
| DOI: | 10.1182/blood-2022-162870 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|